comment cloud with color - stock
How Would Google Run A Clinical Drug Trial?
How would Google run a clinical trial? This was just one of the questions posed by Pfizer’s head of clinical innovation, Craig Lipset, to Google Venture’s general partner, Krishna Yeshwant, M.D. during the keynote fireside chat at the Conference Forum’s 3rd Annual Disruptive Innovations To Advance Clinical Trials Conference (Dpharm) in Boston, Sept. 19 to 20, 2013. By Rob Wright  Continue Reading..
money sign on hand - stock
How Much Are We Willing To Pay For Healthcare?
Recently, Ten-year old Sarah Murnaghan, suffering from end-stage cystic fibrosis (CF), made national headlines when she received a double lung transplant. By Rob Wright  Continue Reading..
two men with bar chart comparison - stock
Want A Strong Company? Find People Who Have Failed
“When I chaired Bradley Pharmaceuticals, they were a commercial–product-driven company,” states Leonard Jacob, M.D., Ph.D. “But they weren’t executing to create the shareholder value people expected from them.” According to Jacob, it is situations like this when people within a company become a driving force as to its success or failure. By Rob Wright  Continue Reading..
Warning – Don’t Confuse 'Made In USA' And 'Inspected By FDA' With Patriotism
A big concern for the pharmaceutical industry is the willingness of insurance companies to continue to reimburse at a level significant enough for pharmaceutical and biotech companies to continue heavy investment into R&D, and thus drive U.S. medical innovation. By Rob Wright  Continue Reading..
How Do You Welcome Your New Employees?
I recently had the pleasure of taking my son to start his freshman year in college at Wooster.. As we drove through campus, we were greeted by cheering students dressed in yellow T-shirts, welcoming us to the school. People were passing out ice cream, food, drinks, while upbeat music played over loud speakers.  Continue Reading..
Will Big Pharma Adapt Or Die?
I recently had the opportunity to meet a former CEO of a top 10 pharma company. During our meeting, we discussed the concept of “adapt or die,” something they know a little bit about from personal experience. By Rob Wright  Continue Reading..
Are Single-Use Manufacturers Destined For The Recycle Bin?
When ATMI’s (NASDAQ: ATMI) CEO, Doug Neugold, gave his keynote presentation at this year’s international single-use summit in Washington, D.C., it may have seemed a bit out of place to some people. By Rob Wright  Continue Reading..
Want To Spark A Little Innovation?
Since its opening in 2008, the Michigan Life Science Innovation Center (MLSIC) has incubated 15 companies, which have created 92 jobs and attracted more than $75 million in investment in southeast Michigan. By Rob Wright  Continue Reading..
How DCAT Is Helping To Sharpen Your Pharmaceutical Sourcing Saw
Traditionally, procurement is viewed as the acquisition of goods and services from an external source with a focus on obtaining the best possible cost. By Rob Wright  Continue Reading..
Details Of Dr. Oz Ambush Dished Up During 2013 DIA
At this year’s DIA meeting in Boston, we tried something a little different, thanks to an idea presented to us by LabCorp, which approached us expressing interest in creating an educational/networking opportunity. By Rob Wright  Continue Reading..
Rob Wright author page

Rob Wright

Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL